8 completed, 5 recruiting, 3 terminated, 3 unknown. 21 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 21 | Completed 8, Recruiting 5, Terminated 3, Unknown 3, Not yet recruiting 2 |
Follow Systemic Vasculitis: new trials by email Literature Review of Systemic Vasculitis trials Research Report on Systemic Vasculitis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| MYTP01 for Immune-Mediated Diseases MYTP01, MYTP01 Placebo - IgA Nephropathy, Kidney Transplant Recipients | Not applicable | Not yet recruiting | Zhejiang Provincial People's Hospital | 160 | 2026-10-01 | 2026-10-28 |
| A Study of CD19 UCAR-T Cells in Subjects With Autoimmune Diseases CD19 UCAR-T cells - Systemic Lupus Erythematosus, Idiopahic Inflammatory Myopathies | Not applicable | Not yet recruiting | Institute of Hematology & Blood Diseases Hospital, China | 24 | 2026-01-30 | 2025-12-19 |
| The Use of Machine Learning Techniques for the Differential Diagnosis Between Eosinophilic Granulomatosis With Polyangiitis and Hypereosinophilic Syndrome Blood draw for the laboratory assessment - EGPA - Eosinophilic Granulomatosis With Polyangiitis, HES - Hypereosinophilic Syndrome | Not applicable | Recruiting | Fondazione IRCCS Policlinico San Matteo di Pavia | 60 | 2025-06-01 | 2025-12-10 |
| Anti-CD19 IL-10/IL15 CAR-NK Cells in Refractory/Relapsed Autoimmune Diseases Anti-CD19 IL-10/IL15 CAR-NK - Systemic Sclerosis (SSc), ANCA Associated Vasculitis (AAV) | Not applicable | Recruiting | Second Affiliated Hospital, Zhejiang University, School of Medicine | 15 | 2025-01-06 | 2025-12-29 |
| An Clinical Study of YTS109 Cell Injection in Subjects With Recurrent/Refractory Autoimmune Disease YTS109 - Systemic Lupus Erythematosus, Systemic Sclerosis | Not applicable | Recruiting | China Immunotech (Beijing) Biotechnology Co., Ltd. | 6 | 2024-10-24 | 2026-10-22 |
| Anti-CD19-CD3E-CAR-T Cells in Relapsed/Refractory Autoimmune Disease Anti-CD19-CD3E-CAR-T cells - Systemic Lupus Erythematosus (SLE), Sjogren's Syndrome | Not applicable | Unknown | Shanghai Changzheng Hospital | 6 | 2024-04-20 | 2024-04-18 |
| Refractory ANCA Associated Vasculitis and Lupus Nephritis Treated With BCMA-targeting CAR-T Cells PRG-1801 （CAR-T against BCMA） - Lupus Nephritis, ANCA Associated Vasculitis | Not applicable | Recruiting | Lingli Dong | 24 | 2024-02-05 | 2024-02-26 |
| Biocollection of Patients With ANCA Associated Vasculitis Blood samples (80 mL), Fecal samples, Urinary sample (20-40 mL) - ANCA-associated Vasculitis | Not applicable | Recruiting | University Hospital, Brest | 100 | 2022-10-27 | 2026-06-25 |
| Comparison of the Efficacy of Leflunomide and Azathioprine for the Maintenance Therapy of ANCA Associated Vasculitis Leflunomide, Azathioprine Tablets - ANCA Associated Vasculitis, Maintenance Therapy | Not applicable | Unknown | Chinese SLE Treatment And Research Group | 114 | 2021-06-30 | 2021-11-30 |
| PRagmatic Analysis of Vitamin D in ANCA-Associated Vasculitis vitamin D - ANCA-associated Vasculitis, Granulomatosis With Polyangiitis | Not applicable | Completed | Christian Pagnoux | 102 | 2020-08-01 | 2023-03-14 |
| Effect of Tofacitinib in Treating ANCA-associated Vasculitis Tofacitinib - ANCA Associated Vasculitis, Drug Use | Not applicable | Completed | Shanghai Zhongshan Hospital | 10 | 2019-12-01 | 2021-07-22 |
| Tailoring Maintenance Therapy to Cluster of Differentiation 5 Positive (CD5+) Regulatory B Cell Recovery in ANCA Vasculitis ENUMERATION OF CD5+ B Cells - ANCA Associated Vasculitis | Not applicable | Terminated | University of North Carolina, Chapel Hill | 9 | 2019-06-28 | 2025-11-26 |
| Soluble CD95 Ligand Role in the Pathophysiology of Antineutrophil Cytoplasmic Antibody (ANCA) Associated Vasculitis blood sample, urine sample - ANCA Associated Vasculitis | Not applicable | Completed | University Hospital, Bordeaux | 48 | 2018-12-14 | 2026-08-17 |
| Aerobic Capacity and Strength Exercise in Takayasu's Arteritis Combined acute physical exercises (strength and aerobic) - Physical Activity, Takayasu Arteritis | Not applicable | Completed | University of Sao Paulo | 12 | 2018-10-01 | 2021-04-30 |
| Yellow Fever Vaccine in Patients With Rheumatic Diseases Yellow Fever vaccine (17D) - Systemic Lupus, Rheumatoid Arthritis | Not applicable | Completed | University of Sao Paulo General Hospital | 600 | 2018-01-31 | 2019-04-26 |
| The Clinical Efficacy of DFPP in Patients With AAGN DFPP&CTX, CTX - Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis | Not applicable | Terminated | Zhi-Hong Liu, M.D. | 14 | 2014-06-01 | 2018-02-06 |
| Magnetic Resonance Angiography vs Ultrasonography in Systemic Large vEssel vasculitiS Ultrasound, MRA - Systemic Vasculitis | Not applicable | Completed | Hospital of Southern Norway Trust | 39 | 2013-12-01 | 2016-02-23 |
| Resistance Exercise in Rheumatic Disease Resistance Exercise - Rheumatoid Arthritis, Systemic Vasculitis | Not applicable | Terminated | Johns Hopkins University | 15 | 2012-05-01 | 2019-04-09 |
| Study of One Protein Implicated in Wegener Disease Physiopathology Endpoint Classification - Wegener's Granulomatosis | Not applicable | Completed | Assistance Publique - Hôpitaux de Paris | 138 | 2010-05-01 | 2026-03-31 |
| RATTRAP: Infliximab Versus Rituximab in Systemic Necrotizing Vasculitides Infliximab, Rituximab - Wegener's Granulomatosis, Churg-Strauss Syndrome | Not applicable | Completed | Assistance Publique - Hôpitaux de Paris | 20 | 2004-05-01 | 2007-11-19 |
Showing 20 of 21. Sign in to see all of them.
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (13) · Granulomatosis with Polyangiitis (6) · Lupus Erythematosus, Systemic (6) · Churg-Strauss Syndrome (5) · Scleroderma, Systemic (5) · Sjogren's Syndrome (5) · Antiphospholipid Syndrome (4) · Arthritis, Rheumatoid (4) · Myositis (4) · Takayasu Arteritis (4) · Microscopic Polyangiitis (3) · Arthritis, Juvenile (2) · Giant Cell Arteritis (2) · Lupus Nephritis (2)
Cardiovascular Diseases (21) · Skin and Connective Tissue Diseases (21) · Vascular Diseases (21) · Autoimmune Diseases (20) · Skin Diseases (20) · Skin Diseases, Vascular (20) · Immune System Diseases (19) · Vasculitis (19) · Connective Tissue Diseases (9) · Musculoskeletal Diseases (9) · Nervous System Diseases (9) · Joint Diseases (7) · Arthritis (6) · Hemic and Lymphatic Diseases (6)
Blood Specimen Collection (3) · Cyclophosphamide (2) · Antilymphocyte Serum (1) · Azathioprine (1) · Cyclosporine (1) · Filgrastim (1) · Infliximab (1) · Leflunomide (1) · Methylprednisolone (1) · Prednisone (1) · Resistance Training (1) · Rituximab (1) · Surveys and Questionnaires (1) · Ultrasonography (1) · Vitamin D (1)
Assistance Publique - Hôpitaux de Paris (2) · China Immunotech (Beijing) Biotechnology Co., Ltd. (1) · Chinese SLE Treatment And Research Group (1) · Christian Pagnoux (1) · Fairview University Medical Center (1) · Fondazione IRCCS Policlinico San Matteo di Pavia (1) · Hospital of Southern Norway Trust (1) · Institute of Hematology & Blood Diseases Hospital, China (1) · Johns Hopkins University (1) · Lingli Dong (1) · Second Affiliated Hospital, Zhejiang University, School of Medicine (1) · Shanghai Changzheng Hospital (1) · Shanghai Zhongshan Hospital (1) · University Hospital, Bordeaux (1) · University Hospital, Brest (1)
China (9) · France (4) · United States (3) · Brazil (2) · Canada (1) · Italy (1) · Norway (1)
Andreas Diamantopoulos, MD (1) · Arne Slungaard (1) · Christian Pagnoux, MD (1) · Eloisa Bonfa, MD, PhD (1) · Huji Xu, MD,Ph.D (1) · Huji Xu, Ph.D, MD (1) · Lindi Jiang, PhD (1) · Lingli Dong, MD (1) · Mathilde De Menthon,, MD, PhD (1) · Rebecca L Manno, M.D. (1) · Samuel K Shinjo (1) · Vimal Derebail, MD (1) · Xinping Tian (1)
PMID 25372085, PMID 34843469, PMID 40866583, PMID 42321206
P01DK058335 (1)